$220 Million is the total value of Krensavage Asset Management, LLC's 23 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 26.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP | $22,555,000 | +39.6% | 130,801 | +4.8% | 10.27% | +14.1% |
| IPXL | Sell | IMPAX LABORATORIES INC | $19,261,000 | +43.7% | 410,944 | -2.9% | 8.77% | +17.4% |
| AMAG | Sell | AMAG PHARMACEUTICALS INC | $18,644,000 | +25.3% | 341,091 | -2.3% | 8.49% | +2.4% |
| TEVA | Buy | TEVA PHARMACEUTICAL-SP ADR | $15,463,000 | +22.7% | 248,200 | +13.2% | 7.04% | +0.3% |
| HYH | Buy | HALYARD HEALTH INC | $14,964,000 | +23.0% | 304,150 | +13.7% | 6.82% | +0.6% |
| SCMP | Sell | SUCAMPO PHARMACEUTICALS-CL A | $14,531,000 | +6.2% | 933,866 | -2.5% | 6.62% | -13.2% |
| ENTA | New | ENANTA | $12,983,000 | – | 424,016 | +100.0% | 5.91% | – |
| CNMD | Sell | CONMED CORP | $12,687,000 | +9.3% | 251,274 | -2.7% | 5.78% | -10.6% |
| MRK | Buy | MERCK & CO. INC. | $12,031,000 | +3.8% | 209,304 | +2.5% | 5.48% | -15.2% |
| OFIX | Sell | ORTHOFIX INTERNATIONAL NV | $11,115,000 | +18.3% | 309,698 | -0.9% | 5.06% | -3.3% |
| HRC | Sell | HILL-ROM HOLDINGS INC | $9,228,000 | +3.2% | 188,327 | -4.0% | 4.20% | -15.7% |
| Buy | AMGEN INC | $9,111,000 | +97.3% | 57,000 | +96.6% | 4.15% | +61.2% | |
| RTIX | Buy | RTI SURGICAL INC | $8,405,000 | -2.1% | 1,701,458 | +3.0% | 3.83% | -20.0% |
| DEPO | Sell | DEPOMED INC | $7,699,000 | +24.9% | 343,546 | -10.2% | 3.51% | +2.1% |
| B108PS | Sell | ACTAVIS PLC | $6,534,000 | +10.3% | 21,954 | -4.6% | 2.98% | -9.8% |
| IVC | INVACARE CORP | $6,498,000 | +15.8% | 334,762 | 0.0% | 2.96% | -5.3% | |
| ABBV | Sell | ABBVIE INC | $4,098,000 | -17.1% | 70,000 | -7.3% | 1.87% | -32.2% |
| Buy | BIOTA PHARMACEUTICALS INC | $3,120,000 | +21.4% | 1,356,652 | +18.3% | 1.42% | -0.8% | |
| New | INDIVIOR PLC | $2,817,000 | – | 1,000,000 | +100.0% | 1.28% | – | |
| THRX | Sell | THERAVANCE INC | $2,534,000 | +4.2% | 161,188 | -6.2% | 1.15% | -14.8% |
| CBRX | COLUMBIA LABORATORIES INC | $1,963,000 | +10.9% | 316,149 | 0.0% | 0.89% | -9.3% | |
| DRAD | DIGIRAD CORP | $1,905,000 | +4.2% | 419,604 | 0.0% | 0.87% | -14.8% | |
| FURX | FURIEX PHARMACEUTICA CMN | $1,422,000 | 0.0% | 145,544 | 0.0% | 0.65% | -18.2% | |
| QLTI | Exit | QLT INC | $0 | – | -17,000 | -100.0% | -0.04% | – |
| LLY | Exit | ELI LILLY & CO | $0 | – | -2,143 | -100.0% | -0.08% | – |
| PFE | Exit | PFIZER INC | $0 | – | -13,447 | -100.0% | -0.23% | – |
| MDCO | Exit | MEDICINES COMPANY | $0 | – | -128,600 | -100.0% | -1.98% | – |
| MNKKQ | Exit | MALLINCKRODT PLC | $0 | – | -50,395 | -100.0% | -2.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.